Mutation in the Hepatitis E Virus Polymerase and Outcome of Ribavirin Therapy (Q36644831)

15 August 2017

Mutation in the Hepatitis E Virus Polymerase and Outcome of Ribavirin Therapy (English)

1 reference

15 August 2017

1 reference

1 reference

Hepatitis E Virus

1 reference

19

Jacques Izopet

1 reference

Florence Legrand-Abravanel

15 August 2017

18

object named as

Florence Abravanel

1 reference

15 August 2017

2

Nassim Kamar

1 reference

15 August 2017

11

Heidi Barth

1 reference

15 August 2017

5

Michael Bismuth

1 reference

15 August 2017

1

Sebastien Lhomme

1 reference

15 August 2017

14

Martine Dubois

1 reference

15 August 2017

3

Florence Nicot

1 reference

15 August 2017

Jacques Ducos

4

1 reference

15 August 2017

Valerie Garrigue

6

1 reference

15 August 2017

Joelle Petitjean-Lecherbonnier

7

1 reference

15 August 2017

Isabelle Ollivier

8

1 reference

15 August 2017

Elodie Alessandri-Gradt

9

1 reference

15 August 2017

Odile Goria

10

1 reference

15 August 2017

Peggy Perrin

12

1 reference

15 August 2017

Karine Saune

13

1 reference

15 August 2017

Romain Carcenac

15

1 reference

15 August 2017

Caroline Lefebvre

16

1 reference

15 August 2017

Nicolas Jeanne

17

1 reference

15 August 2017

language of work or name

English

0 references

publication date

28 December 2015

1 reference

Antimicrobial Agents and Chemotherapy

15 August 2017

1 reference

15 August 2017

60

1 reference

15 August 2017

3

1 reference

15 August 2017

1608-1614

1 reference

Murine norovirus (MNV-1) exposure in vitro to the purine nucleoside analog Ribavirin increases quasispecies diversity

15 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4775994

Variability and pathogenicity of hepatitis E virus genotype 3 variants

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4775994

An Early Viral Response Predicts the Virological Response to Ribavirin in Hepatitis E Virus Organ Transplant Patients

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4775994

Relevance of chronic hepatitis E in liver transplant recipients: a real-life setting

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4775994

Increased replicative fitness can lead to decreased drug sensitivity of hepatitis C virus

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4775994

Consensus proposals for classification of the family Hepeviridae

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4775994

Ribavirin improves the IFN-γ response of natural killer cells to IFN-based therapy of hepatitis C virus infection.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4775994

Ribavirin for chronic hepatitis E virus infection in transplant recipients

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4775994

Neuralgic amyotrophy and hepatitis E virus infection

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4775994

Hepatitis E virus infection

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4775994

Ribavirin inhibits in vitro hepatitis E virus replication through depletion of cellular GTP pools and is moderately synergistic with alpha interferon

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4775994

Zoonotic and foodborne transmission of hepatitis E virus

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4775994

Hepatitis E: clinical presentation in disease-endemic areas and diagnosis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4775994

Ribavirin exerts differential effects on functions of Cd4 Th1, Th2, and regulatory T cell clones in hepatitis C.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4775994

Hepatitis E virus strains in rabbits and evidence of a closely related strain in humans, France

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4775994

Hepatitis E virus quasispecies and the outcome of acute hepatitis E in solid-organ transplant patients

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4775994

A naturally occurring human/hepatitis E recombinant virus predominates in serum but not in faeces of a chronic hepatitis E patient and has a growth advantage in cell culture

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4775994

Hepatitis E virus and neurologic disorders

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4775994

Cross-species infections of cultured cells by hepatitis E virus and discovery of an infectious virus-host recombinant

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4775994

Hepatitis E virus genotype 3 diversity, France

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4775994

Severe thrombocytopenia associated with acute hepatitis E virus infection

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4775994

Ribavirin suppresses eIF4E-mediated oncogenic transformation by physical mimicry of the 7-methyl guanosine mRNA cap

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4775994

Protracted fecal shedding of HEV during ribavirin therapy predicts treatment relapse

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4775994

A mutation in the hepatitis E virus RNA polymerase promotes its replication and associates with ribavirin treatment failure in organ transplant recipients

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4775994

Characterization of the polyproline region of the hepatitis E virus in immunocompromised patients

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4775994

Guillain-Barré syndrome associated with preceding hepatitis E virus infection

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4775994

Influence of polyproline region and macro domain genetic heterogeneity on HEV persistence in immunocompromised patients

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4775994

Genotype 3 diversity and quantification of hepatitis E virus RNA.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4775994

Ribavirin treatment of acute and chronic hepatitis E: a single-centre experience

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4775994

Hepatitis E virus-associated aplastic anaemia: the first case of its kind

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4775994

Hepatitis E virus and the kidney in solid-organ transplant patients

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4775994

Acute pancreatitis: A rare complication of acute hepatitis E

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4775994

Characteristics of autochthonous hepatitis E virus infection in solid-organ transplant recipients in France

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4775994

Influence of immunosuppressive therapy on the natural history of genotype 3 hepatitis-E virus infection after organ transplantation

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4775994

Persistent carriage of hepatitis E virus in patients with HIV infection.

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4775994

Chronic hepatitis after hepatitis E virus infection in a patient with non-Hodgkin lymphoma taking rituximab.

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4775994

Hepatitis E virus and chronic hepatitis in organ-transplant recipients

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4775994

Transfusion-associated hepatitis E, France

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4775994

Identification of a ribavirin-resistant NS5B mutation of hepatitis C virus during ribavirin monotherapy

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4775994

The broad-spectrum antiviral ribonucleoside ribavirin is an RNA virus mutagen

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4775994

The antiviral compound ribavirin modulates the T helper (Th) 1/Th2 subset balance in hepatitis B and C virus-specific immune responses

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4775994

Severe thrombocytopenia associated with acute autochthonous hepatitis E

20 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26711757

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Molecular virology of hepatitis E virus

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26711757

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Ribavirin for Chronic Hepatitis E Virus Infection

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26711757

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1128/AAC.02496-15

1 reference

15 August 2017

1 reference

15 August 2017

PubMed publication ID

26711757

1 reference